SHOULDER INNOVATIONS, INC. Financing Cash Flow
SHOULDER INNOVATIONS, INC. (SI) reported Financing Cash Flow of $17.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$84.00K, a 100.46% decline year-over-year.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $101.00K, a 99.49% decline year-over-year.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$2.00M.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $108.87M, a 164856.06% increase year-over-year.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $144.96M, a 219531.82% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $66.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $17.00K 10-Q · filed 2026-08-06 | -$1.98M derived: sum of 3 quarters · filed 2026-08-06 | $106.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $101.00K 10-Q · filed 2026-05-13 | -$1.90M derived: sum of 2 quarters · filed 2026-05-13 | $106.97M derived: sum of 3 quarters · filed 2026-05-13 | $125.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $106.87M derived: sum of 2 quarters · filed 2026-03-10 | $125.16M derived: sum of 3 quarters · filed 2026-08-06 | $144.96M 10-K · filed 2026-03-10 |
| 2025-09-30 | $108.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $127.16M derived: sum of 2 quarters · filed 2026-08-06 | $146.96M 10-Q · filed 2025-11-12 | $146.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $18.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $38.08M 10-Q · filed 2026-08-06 | $38.08M derived: sum of 3 quarters · filed 2026-08-06 | $38.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $19.79M 10-Q · filed 2026-05-13 | $19.79M derived: sum of 2 quarters · filed 2026-05-13 | $19.86M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $66.00K derived: sum of 2 quarters · filed 2026-03-10 | $66.00K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $66.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |